ArticleThe New England journal of medicine2018
Osimertinib in EGFR Mutation–Positive Advanced NSCLC.
Elisa Roca et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleThe New England journal of medicine2018
Elisa Roca et al.PubMed ↗Publisher ↗
No numbers read from the abstract.